Service

Joint Commission Laboratory Accreditation Readiness

Last updated: November 2026

Joint Commission laboratory readiness reviews a laboratory's quality system against applicable CLIA requirements and the Joint Commission standards for its accreditation survey. Integral Healthcare Solutions (IHS) maps applicable CLIA and Joint Commission requirements to the procedure and record that shows each, drafts what is missing for your laboratory director to approve, and runs a mock survey.

This page is part of IHS's accreditation line. The Joint Commission decides its accreditation, and your laboratory deals with it directly.

What is Joint Commission laboratory accreditation?

It is accreditation by the Joint Commission that a laboratory can use to meet CLIA requirements and hold a certificate of accreditation. A CMS chart of approved accreditation organizations under CLIA, dated September 2026, lists seven, and The Joint Commission is one of them, marked for every specialty and subspecialty on the chart (opened 2026-11-05). The CMS accrediting organizations page lists Clinical Laboratories (CLIA) among its certified deemed programs and calls the accreditation route voluntary (page opened 2026-11-05, last modified 08/17/2026).

The federal text is 42 CFR Part 493, Laboratory Requirements, the CLIA rules (eCFR text built 2026-11-04, opened 2026-11-05). Section 493.551(a) says: “CMS may deem a laboratory to meet all applicable CLIA program requirements through accreditation by a private nonprofit accreditation program (that is, grant deemed status), or may exempt from CLIA program requirements all State licensed or approved laboratories in a State that has a State licensure program established by law, if the following conditions are met:”

For either route, the accreditation or state licensure program must be equal to or more stringent than the CLIA condition-level requirements, and the laboratory would have to meet them if inspected against them. The program must satisfy that subpart's requirements and have CMS approval. The laboratory must authorize the program to release all required records and information to CMS and permit inspections as Part 493 outlines.

Section 493.3(a) says that, except as specified in paragraph (b), a laboratory will be cited as out of compliance with section 353 of the Public Health Service Act unless it holds a current, unrevoked or unsuspended certificate of waiver, registration, compliance, PPM procedures or accreditation, issued by HHS and applicable to the category of examinations or procedures it performs, or is CLIA-exempt. Paragraph (b) excludes forensic-only testing; research testing that does not report patient-specific results for diagnosis, prevention, treatment or individual health assessment; and drug testing in SAMHSA-certified laboratories that meets SAMHSA guidelines and regulations. All other testing conducted by a SAMHSA-certified laboratory remains subject to CLIA.

The Joint Commission's laboratory services page says a laboratory must hold a non-waived CLIA certificate to apply, along with other eligibility conditions (page opened 2026-11-05). It says its standards are laid out in its comprehensive accreditation manuals, that every accredited organization receives access to E-dition, its electronic standards manual, and that it does not offer book or e-book manuals for every program (pages opened 2026-11-06). IHS works from the standards edition your laboratory is licensed to use.

Who needs it and what triggers it

A laboratory needs this work when it performs nonwaived testing, holds or wants Joint Commission accreditation, and cannot show that its written quality system matches practice. The usual triggers:

How IHS helps

IHS tests the quality system as a surveyor would. The method:

  1. Gap assessment of the written quality system against Part 493, and against the Joint Commission materials your laboratory supplies.
  2. Evidence index tying each requirement to the procedure, log, record or competency file that shows it.
  3. Drafts of missing quality system procedures, for your laboratory director and technical staff to approve.
  4. Mock survey with test-process tracers, document review and interviews, and a ranked findings list.

Your laboratory supplies its procedure manual, quality plan, certificate status, a sample of records, committee minutes, its Joint Commission materials and any survey date.

The limit: IHS does not attend the survey, predict findings or take part in the Joint Commission's decision. IHS does not communicate with the Joint Commission; your laboratory's named contact does.

What to have ready

The table below is a selection from 42 CFR Part 493, summarized in IHS's words (eCFR text built 2026-11-04, opened 2026-11-05).

EvidenceSectionWhat the text asks for
Current CLIA certificate for the testing you perform493.3A current, unrevoked or unsuspended certificate for the category of testing, or CLIA-exempt status, subject to paragraph (b).
Written quality system policies and procedures493.1200For nonwaived testing: written policies that implement and monitor a quality system across all testing phases and general systems, with a quality assessment component.
Procedure manual and director approvals493.1251A manual covering all tests, assays and examinations, available to and followed by personnel; procedures and changes approved, signed and dated by the current laboratory director before use.
Performance specification records493.1253Before patient reporting, document verification of accuracy, precision and reportable range for unmodified FDA-cleared or approved systems, and verify that manufacturer reference intervals fit the laboratory's patient population. For modified FDA-cleared or approved systems, systems not subject to FDA clearance or approval, and systems without manufacturer performance specifications, establish all applicable performance specifications under 493.1253(b)(2), including reference intervals, before reporting patient results. Paragraph (a) excepts systems this laboratory used before April 24, 2003.
Control procedure records493.1256Minimums apply at least once each day patient specimens are assayed or examined, subject to the specialty rules and to a CMS-approved equivalent-quality procedure specified in Appendix C of the State Operations Manual.
Corrective action records493.1282Document all corrective actions. If control or calibration results fail acceptance criteria, evaluate all patient results in the unacceptable run and since the last acceptable run for adverse effects, and correct the problem.
Proficiency testing enrollment, handling and evaluation493.801 and 493.1236Enroll in an HHS-approved PT program meeting subpart I for each specialty and subspecialty for which certification is sought. Test with the routine patient workload and methods, with tester and director attestations. Do not communicate about PT sample results between laboratories or across testing sites or locations until after the date results must be reported to the PT program. Handle samples as patient specimens only up to the point of referral; follow the referral restrictions in 493.801(b)(5). Document evaluation, with accuracy verification at least twice a year for tests outside subpart I or without compatible PT samples.
Retention schedule493.1105By record type: procedures at least 2 years after discontinuance; performance specification records for the period of use and at least 2 years; pathology test reports at least 10 years after reporting. Blood-related records and reports, and slide, block and tissue periods, follow the separate provisions of paragraph (a). If the laboratory ceases operation, it must arrange for all records and applicable slides, blocks and tissue to remain retained and available for the required periods.

To walk this list against your laboratory's records, start with the introductory call.

How it compares

Accreditation changes who inspects the laboratory in the ordinary course. It does not take the laboratory out of CLIA. Under 493.551(b), the laboratory must obtain its certificate, pay applicable fees and meet subpart H proficiency testing requirements. It must authorize its PT organization to give results to its accreditor for monitoring and for making annual PT results, with information needed to interpret them, available on a reasonable basis upon anyone's request. It must authorize its accreditor to report unsuccessful PT participation to CMS or its agent and notify CMS of resulting actions within 30 days after initiation.

CMS or a CMS agent may conduct a validation inspection of any accredited laboratory at any time during its hours of operation (493.1780(a)). If a validation or complaint inspection finds noncompliance with one or more condition-level requirements, a laboratory with a certificate of accreditation is subject to a full review by CMS (493.1780(c)(1)).

Other routes exist: 493.3(a)(1) lists several certificate types, and 493.551(a) permits exemption for state-licensed or state-approved laboratories only through a state licensure program established by law that meets the same conditions. The CMS list of exempt states names Washington and New York (version dated 10/15/2024, opened 2026-11-05); confirm current status with the state. IHS does not tell you which route or accreditor to choose.

What it costs

The total has three parts: the Joint Commission's fees, consulting fees and your internal staff time. The Joint Commission does not publish a fee schedule on the pages we reviewed; fees depend on scope. See its pricing page (page opened 2026-11-05). Verify current fees with the Joint Commission.

IHS scopes each engagement after a free introductory call.

What this is not

IHS is not an accrediting body or a CLIA regulator and does not grant accreditation or a certificate.

This page is not legal advice. IHS is a consulting firm, not a law firm.

IHS does not guarantee a survey result, does not write clinical or technical content without your laboratory director's approval, and does not file anything with CMS, a state agency or the Joint Commission. Your laboratory submits.

Frequently asked questions

What does Joint Commission laboratory readiness cover?

It covers the written quality system for all testing phases, reviewed against applicable CLIA requirements and Joint Commission standards. You receive an evidence index, drafted procedures and a ranked findings list.

Is the Joint Commission approved by CMS for laboratories?

A CMS chart dated September 2026 lists The Joint Commission among seven approved accreditation organizations under CLIA, marked for every specialty and subspecialty on the chart (opened 2026-11-05). CMS describes the accreditation route as voluntary. Confirm eligibility with the Joint Commission.

Does accreditation replace a CLIA inspection?

Partly. Under 42 CFR 493.551(a), CMS may deem a laboratory to meet CLIA program requirements through an approved accreditation program, if the conditions in that paragraph are met. Under 493.1780(a), CMS or a CMS agent may conduct a validation inspection of an accredited laboratory at any time during its hours of operation.

What must the written quality system cover?

Section 493.1200(a) says each laboratory that performs nonwaived testing must establish and maintain written policies and procedures that implement and monitor a quality system for all phases of the total testing process (preanalytic, analytic and postanalytic) as well as general laboratory systems. Paragraph (b) requires quality assessment that identifies, evaluates and resolves problems through ongoing monitoring for continuous improvement. Paragraph (c) requires components appropriate to the laboratory's testing specialties and subspecialties, services and clients.

What is a mock survey and what do we receive?

A mock survey is a rehearsal run as a surveyor would run it, with test-process tracers, document review and interviews. You receive a ranked findings list and an evidence index.

Can IHS speak with the Joint Commission for us?

No. IHS does not communicate with the Joint Commission or submit anything to it. Your laboratory's named contact does, and IHS prepares the documents behind it.

Which Joint Commission standards does IHS work from?

The Joint Commission says its standards are laid out in its comprehensive accreditation manuals, that every accredited organization receives access to E-dition, its electronic standards manual, and that it does not offer book or e-book manuals for every program (pages opened 2026-11-06). IHS works from the standards edition your laboratory is licensed to use.

What does it cost?

The total has three parts: the Joint Commission's fees, consulting fees and your staff time. The Joint Commission does not publish a fee schedule on the pages we reviewed. Verify current fees with it. IHS scopes each engagement after a free introductory call.

Related pages

Recent changes

  • Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities

    · Substance Abuse and Mental Health Services Administration

    Full title: Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies (Notice; FR Doc. 2026-22321)

    Substance Abuse and Mental Health Services Administration states: “The Department of Health and Human Services (HHS) provides notice of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.”

    Checked

  • REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment

    · Centers for Medicare & Medicaid Services

    Full title: REVISED: Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits (QSO-18-14-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-18-14-CLIA, "Clarification Regarding Fine Needle Aspiration(FNA) Specimen Adequacy Assessment, RapidOn-site Evaluation (ROSE) and Workload Limits", on October 16, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments: Provide Input on Proposed Changes by December 7

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS is seeking input on proposed changes to the rules implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Comment period, in the source's words: “Read the CLIA; Virtual Access, Gynecologic Cytology Proficiency Testing, Personnel Qualifications & Other Changes proposed rule and submit your comments by December 7.”

    Checked

  • REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance

    · Centers for Medicare & Medicaid Services

    Full title: REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance (QSO-23-15-CLIA REVISED)

    CMS posted a revised version of policy memo QSO-23-15-CLIA, "REVISED Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency (PHE) Guidance", on October 14, 2026.

    Checked

  • Clinical Laboratory Improvement Amendments of 1988 (CLIA)

    · Centers for Medicare & Medicaid Services

    Full title: Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes (Proposed rule; FR Doc. 2026-20613)

    Centers for Medicare & Medicaid Services states: “This proposed rule would amend the Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations to allow for virtual access under the CLIA certificate of the primary testing laboratory that generated the data, with the exception of the subspecialty of cytology, and the use of digital images for gynecologic cytology proficiency testing. This proposed rule also includes proposed changes to personnel qualification requirements and other proposed changes pertaining to SARS-CoV-2 reporting requirements, certificate requirements, test reporting requirements, enforcement requirements, public consultation requirements, and editorial and technical updates. These proposed updates aim to strengthen the Federal oversight of clinical laboratories and ensure accurate and reliable patient test results while adapting to modern technological capabilities and industry needs, including workforce shortages.”

    Checked

More: Laboratories · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session